Ameriprise’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.2M Buy
877,910
+12,184
+1% +$225K ﹤0.01% 1482
2025
Q1
$15.1M Sell
865,726
-46,484
-5% -$812K ﹤0.01% 1493
2024
Q4
$15.8M Buy
912,210
+58,919
+7% +$1.02M ﹤0.01% 1489
2024
Q3
$15.9M Buy
853,291
+482,818
+130% +$8.99M ﹤0.01% 1460
2024
Q2
$5.71M Buy
370,473
+500
+0.1% +$7.7K ﹤0.01% 2212
2024
Q1
$5.46M Buy
369,973
+84,663
+30% +$1.25M ﹤0.01% 2305
2023
Q4
$4.07M Sell
285,310
-581,537
-67% -$8.3M ﹤0.01% 2503
2023
Q3
$12.1M Buy
866,847
+125,095
+17% +$1.74M ﹤0.01% 1546
2023
Q2
$8.73M Buy
741,752
+264,141
+55% +$3.11M ﹤0.01% 1889
2023
Q1
$5.49M Sell
477,611
-949,109
-67% -$10.9M ﹤0.01% 2254
2022
Q4
$17.7M Sell
1,426,720
-891,172
-38% -$11.1M 0.01% 1297
2022
Q3
$30.6M Buy
2,317,892
+48,856
+2% +$645K 0.01% 920
2022
Q2
$31.5M Buy
2,269,036
+1,676,098
+283% +$23.2M 0.01% 933
2022
Q1
$8.69M Sell
592,938
-508,889
-46% -$7.46M ﹤0.01% 2031
2021
Q4
$14.8M Buy
1,101,827
+463,050
+72% +$6.21M ﹤0.01% 1643
2021
Q3
$9.4M Sell
638,777
-133,858
-17% -$1.97M ﹤0.01% 1903
2021
Q2
$14.1M Sell
772,635
-740,241
-49% -$13.5M ﹤0.01% 1640
2021
Q1
$26.3M Buy
1,512,876
+12,111
+0.8% +$210K 0.01% 1119
2020
Q4
$26.1M Buy
1,500,765
+308,063
+26% +$5.35M 0.01% 1060
2020
Q3
$16.4M Sell
1,192,702
-83,203
-7% -$1.15M 0.01% 1207
2020
Q2
$18.3M Buy
1,275,905
+14,918
+1% +$214K 0.01% 1107
2020
Q1
$13.8M Buy
1,260,987
+291,026
+30% +$3.18M 0.01% 1169
2019
Q4
$20.7M Buy
969,961
+423,119
+77% +$9.03M 0.01% 1173
2019
Q3
$12.6M Sell
546,842
-274,610
-33% -$6.31M 0.01% 1520
2019
Q2
$16.2M Buy
821,452
+30,385
+4% +$598K 0.01% 1328
2019
Q1
$15.4M Buy
791,067
+89,139
+13% +$1.74M 0.01% 1331
2018
Q4
$11.6M Sell
701,928
-22,695
-3% -$374K 0.01% 1479
2018
Q3
$16.8M Sell
724,623
-14,377
-2% -$333K 0.01% 1446
2018
Q2
$16.1M Sell
739,000
-14,068
-2% -$306K 0.01% 1344
2018
Q1
$13.3M Sell
753,068
-358,525
-32% -$6.33M 0.01% 1429
2017
Q4
$20.9M Sell
1,111,593
-215,008
-16% -$4.04M 0.01% 1035
2017
Q3
$29.1M Buy
1,326,601
+709,983
+115% +$15.6M 0.01% 823
2017
Q2
$14.9M Buy
616,618
+181,599
+42% +$4.38M 0.01% 1246
2017
Q1
$12.1M Buy
435,019
+81,319
+23% +$2.27M 0.01% 1379
2016
Q4
$8.64M Buy
353,700
+11,008
+3% +$269K ﹤0.01% 1639
2016
Q3
$8.56M Buy
342,692
+26,776
+8% +$669K ﹤0.01% 1580
2016
Q2
$6.52M Buy
315,916
+12,662
+4% +$261K ﹤0.01% 1738
2016
Q1
$6.09M Sell
303,254
-236
-0.1% -$4.74K ﹤0.01% 1803
2015
Q4
$6.14M Sell
303,490
-1,313
-0.4% -$26.6K ﹤0.01% 1834
2015
Q3
$7.07M Sell
304,803
-3,158
-1% -$73.2K ﹤0.01% 1735
2015
Q2
$7.93M Sell
307,961
-61,966
-17% -$1.59M ﹤0.01% 1786
2015
Q1
$12.3M Buy
369,927
+36,261
+11% +$1.2M 0.01% 1395
2014
Q4
$10.1M Buy
333,666
+33,586
+11% +$1.02M 0.01% 1489
2014
Q3
$7.3M Sell
300,080
-311,428
-51% -$7.57M ﹤0.01% 1734
2014
Q2
$17.6M Buy
611,508
+14,350
+2% +$412K 0.01% 1112
2014
Q1
$16.7M Buy
597,158
+100,225
+20% +$2.8M 0.01% 1131
2013
Q4
$13M Sell
496,933
-29,875
-6% -$781K 0.01% 1302
2013
Q3
$12.1M Buy
526,808
+1,024
+0.2% +$23.6K 0.01% 1341
2013
Q2
$13.7M Buy
+525,784
New +$13.7M 0.01% 1230